Academic Journal

Butyrate histone deacetylase inhibitors.

التفاصيل البيبلوغرافية
العنوان: Butyrate histone deacetylase inhibitors.
المؤلفون: Steliou, Kosta, Boosalis, Michael S., Perrine, Susan P., Sangerman, José, Faller, Douglas V.
سنة النشر: 2012
المجموعة: Boston University: OpenBU
مصطلحات موضوعية: Acylcarnitine, Butyrate, Butyrylcarnitine, Carnitine, Histone deacetylase
جغرافية الموضوع: United States
الوصف: In addition to being a part of the metabolic fatty acid fuel cycle, butyrate is also capable of inducing growth arrest in a variety of normal cell types and senescence-like phenotypes in gynecological cancer cells, inhibiting DNA synthesis and cell growth in colonic tumor cell lines, suppressing hTERT mRNA expression and telomerase activity in human prostate cancer cells, and inducing stem cell differentiation and apoptosis by DNA fragmentation. It regulates gene expression by inhibiting histone deacetylases (HDACs), enhances memory recovery and formation in mice, stimulates neurogenesis in the ischemic brain, promotes osteoblast formation, selectively blocks cell replication in transformed cells (compared to healthy cells), and can prevent and treat diet-induced obesity and insulin resistance in mouse models of obesity, as well as stimulate fetal hemoglobin expression in individuals with hematologic diseases such as the thalassemias and sickle-cell disease, in addition to a multitude of other biochemical effects in vivo. However, efforts to exploit the potential of butyrate in the clinical treatment of cancer and other medical disorders are thwarted by its poor pharmacological properties (short half-life and first-pass hepatic clearance) and the multigram doses needed to achieve therapeutic concentrations in vivo. Herein, we review some of the methods used to overcome these difficulties with an emphasis on HDAC inhibition. ; Published version
نوع الوثيقة: article in journal/newspaper
وصف الملف: p. 192 - 198
اللغة: English
تدمد: 2164-7844
Relation: Biores Open Access; https://www.ncbi.nlm.nih.gov/pubmed/23514803; Kosta Steliou, Michael S Boosalis, Susan P Perrine, José Sangerman, Douglas V Faller. 2012. "Butyrate histone deacetylase inhibitors." Biores Open Access, Volume 1, Issue 4, pp. 192 - 198. https://doi.org/10.1089/biores.2012.0223; https://hdl.handle.net/2144/40827; 0000-0002-5530-3194 (Steliou, Kosta); 31440
DOI: 10.1089/biores.2012.0223
الاتاحة: https://hdl.handle.net/2144/40827
https://www.ncbi.nlm.nih.gov/pubmed/23514803
https://doi.org/10.1089/biores.2012.0223
Rights: Attribution 4.0 International ; http://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.26ECEB55
قاعدة البيانات: BASE
الوصف
تدمد:21647844
DOI:10.1089/biores.2012.0223